CLINICAL EFFECT AND NURSING EXPERIENCE OF USING THE WHOLE BRAIN SIB-IMRT IN TREATING BRAIN METASTASES OF EGFR WILD-TYPE OR DRUG-RESISTANT LUNG ADENOCARCINOMA
Objective To explore the treatment and nursing of brain metastases of EGFR wild-type or drug-resistant lung adenocarcinoma.Methods 46 cases of brain metastases of EGFR wild-type or drug-re-sistant lung adenocarcinoma were randomly divided into two groups,with 23 cases in each group.Both groups were treated with the whole brain SIB-IMRT,while the observation group was treated with bevaci-zumab in addition.Both groups received evidence-based nursing intervention.The clinical effect of the two groups was compared.Results The clinical effect,peritumoral edema volume,health index and life satis-faction of the observation group were better than those of the control group(P<0.05).Conclusion The whole brain SIB-IMRT used with bevacizumab is effective and safe in treating brain metastases of EGFR wild-type or drug-resistant lung adenocarcinoma.